The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

trinetx.com

Founded Year

2013

Stage

Acq - Fin | Alive

Total Raised

$53M

About TriNetX

TriNetX is the global health research network that optimizes clinical research and enables discoveries through the creation of real-world evidence. TriNetX combines real-time access to longitudinal clinical data with analytics to answer complex research questions.

TriNetX Headquarter Location

125 Cambridgepark Drive Suite 500

Cambridge, Massachusetts, 02140,

United States

857-285-6037

ESPs containing TriNetX

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Biopharmaceuticals

Companies in this market offer alternative datasets that can supplement clinical trial data and improve the likelihood of trial success. These companies collect data from a variety of sources, such as patient registries, EHRs, insurance databases, social media, and patient research networks.

TriNetX named as Leader among 15 other companies, including Datavant, Syapse, and Evidation.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing TriNetX

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

TriNetX is included in 6 Expert Collections, including Clinical Trials Tech.

C

Clinical Trials Tech

326 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

C

Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare

D

Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

D

Digital Health

13,066 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

C

Clinical Trials Tech Market Map

108 items

This CB Insights Tech Market Map highlights 100+ clinical trials tech companies that are addressing 8 distinct technology priorities that pharmaceutical companies and CROs face.

B

Biopharma Tech

326 items

TriNetX Patents

TriNetX has filed 2 patents.

The 3 most popular patent topics include:

  • Business intelligence
  • Data management
  • Data modeling
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/13/2017

Data modeling, Database management systems, Data management, Databases, Business intelligence

Application

Application Date

3/13/2017

Grant Date

Title

Related Topics

Data modeling, Database management systems, Data management, Databases, Business intelligence

Status

Application

Latest TriNetX News

GlobalData Plc: Big Data Crucial for Business Strategy Across the Pharma Value Chain

May 18, 2022

Leading Public Big Data Vendors Amazon, International Business Machines, Microsoft, Oracle, and SAP SE Leading Private Big Data Vendors Antidote Technologies, BenevolentAI, Deep Genomics, Deep Lens, Exscientia, Healx, Insilico Medicine, Lantern Pharma, Medidata Solutions, Owkin, Recursion Pharmaceuticals, Sensyne Health, Syapse, Syneos Health, TriNetX, and Unlearn.AI Leading Adopters of Big Data Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co, Moderna, Novartis, Pfizer, Roche, Sanofi, Takeda, and Tevaz Big Data in Pharmaceuticals Market Report Scope Overview of the current and future use cases of big data analytics in the pharma industry, across the value chain. Insightful review of the healthcare, technology, regulatory, and macroeconomic trends. Each trend is independently researched to provide a qualitative analysis of its implications in the big data space. Reports of the revenue opportunity forecast in the data and analytical markets in the pharma industry from 2020 to 2025, spanning three technology segments and 49 geographical markets. Key players in the big data space, with a focus on technology providers and pharma adopters. Industry analysis of big data in the context of jobs in the pharma industry, use of real-world evidence in post-marketing studies, social media, and several pharma-specific case studies. Deals analysis: outline of key deals within the big data space over the past three years, including mergers and acquisitions, strategic partnerships, and funding. Reasons to Buy Assess who the leading technology players are in the big data space, as well as leading pharma adopters. See examples of how pharma companies are integrating big data analytics into their value chains. Understand what trends are driving the big data space and challenges that exist for pharma in the space. See how the big data landscape is evolving, with a review of company activity including mergers and acquisitions (M&A), strategic partnerships, and funding deals, as well as job analysis. Assess the impact of COVID-19 on big data analytics. FAQs What was the global data and analytics market size in the pharmaceutical sector in 2020? The global data and analytics market in the pharmaceutical sector was valued at $1.4 billion in 2020. What are the key trends impacting the big data theme in the pharmaceuticals sector? The key trends impacting the big data theme in the pharmaceuticals sector are healthcare trends, technological trends, regulatory trends, and macroeconomic trends. What are the big data value chains in the pharmaceuticals market? The big data value chains in the pharmaceuticals market are big data generation, big data management, and big data product development. Who are the leading public big data vendors in the pharmaceuticals market? The public big data vendors in the pharmaceuticals market are Amazon, International Business Machines, Microsoft, Oracle, and SAP SE. Who are the leading private big data vendors in the pharmaceuticals market? The private big data vendors in the pharmaceuticals market are Antidote Technologies, BenevolentAI, Deep Genomics, Deep Lens, Exscientia, Healx, Insilico Medicine, Lantern Pharma, Medidata Solutions, Owkin, Recursion Pharmaceuticals, Sensyne Health, Syapse, Syneos Health, TriNetX, and Unlearn.AI. Who are the leading adopters of big data in the pharmaceuticals market? The key adopters of big data in the pharmaceuticals market are Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co, Moderna, Novartis, Pfizer, Roche, Sanofi, Takeda, and Tevaz. Related reports Big Data in Oil & Gas – Thematic Research - Click h ere About us GlobalData is a leading provider of data, analytics, and insights on the world's largest industries. In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision makers to predict and navigate the future. This is why GlobalData's mission is to help our clients to decode the future and profit from faster, more informed decisions. As a leading information services company, thousands of clients rely on GlobalData for trusted, timely, and actionable intelligence. Our solutions are designed to provide a daily edge to professionals within corporations, financial institutions, professional services, and government agencies. Media Contacts

TriNetX Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

TriNetX Rank

  • When was TriNetX founded?

    TriNetX was founded in 2013.

  • Where is TriNetX's headquarters?

    TriNetX's headquarters is located at 125 Cambridgepark Drive, Cambridge.

  • What is TriNetX's latest funding round?

    TriNetX's latest funding round is Acq - Fin.

  • How much did TriNetX raise?

    TriNetX raised a total of $53M.

  • Who are the investors of TriNetX?

    Investors of TriNetX include The Carlyle Group, Deerfield Management, MPM Capital, F2 Ventures, Merck Global Health Innovation Fund and 5 more.

  • Who are TriNetX's competitors?

    Competitors of TriNetX include Savana and 6 more.

You May Also Like

Aetion Logo
Aetion

Aetion delivers real-world evidence for life sciences companies, payers, at-risk providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce rapid and scientifically validated answers on treatments, costs, and outcomes. Aetion informs health care's most critical decisions - what works best, for whom, and when - to guide treatment development, commercialization, and payment values into health care's modern era.

ConcertAI Logo
ConcertAI

ConcertAI specializes in integrated clinical RWD, AI solutions and outcomes science with a large RWD oncology dataset. ConcertAI develops a medical research tool suite that offers care-based oncology research and data analytics.

V
Verantos

Verantos specializes in high accuracy real-world evidence (RWE) generation. The Verantos RWE platform integrates heterogeneous real-world data sources and generates evidence with the accuracy necessary for regulatory and reimbursement use. The Verantos RWE platform leverages data science and artificial intelligence along with advanced data sources to generate RWE capable of supporting clinical assertions.

Tempus Logo
Tempus

Tempus builds a library of molecular and clinical data as well as a corresponding operating system for data accessibility and use. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. It provides genomic sequencing services and molecular and therapeutic data analysis to empower physicians to make real-time, data-driven decisions.

Clinerion Logo
Clinerion

Clinerion enables early patient access to treatments through solutions for clinical trial patient recruitment, real-world evidence, and market access. Clinerion's Patient Recruitment System accelerates clinical research by improving the efficiency and effectiveness of trial recruitment.

Owkin Logo
Owkin

Owkin specializes in AI technologies applied to clinical research with the aim of developing better drugs and treatments for patients. The company's purpose is to empower researchers in hospitals, universities and the biopharma industry to i) understand why drug efficacy varies from patient to patient, ii) improve the drug development process and iii) to help identify key drugs and treatments for each individual patient to improve patient outcomes. The company's precision medicine platform aims to enable medical insights for drug discovery and development by connecting life sciences firms with academic researchers and hospitals. The Owkin platform aims to enable partners to uncover siloed datasets while maintaining patient privacy and securing proprietary data using Federated Learning and innovative collaborative AI technology.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.